Evidence map›Paper›PMID 26780498›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2016

Critical Points in Tumorigenesis: A Carcinogen-Initiated Phase Transition Analyzed via Single-Cell Proteomics.

Suresh Kumar Poovathingal, Nataly Kravchenko-Balasha, Young Shik Shin, Raphael David Levine, James R Heath

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Critical transition and reversion of tumorigenesis.Experimental & molecular medicine · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Personalized disease signatures through information-theoretic compaction of big cancer data.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Suresh Kumar PoovathingalDivision of Chemistry and Chemical Engineering, California Institute of Technology, MC 127-72, 1200 E. California Blvd, Pasadena, CA, 91125, USA.
Nataly Kravchenko-BalashaDivision of Chemistry and Chemical Engineering, California Institute of Technology, MC 127-72, 1200 E. California Blvd, Pasadena, CA, 91125, USA.
Young Shik ShinDivision of Chemistry and Chemical Engineering, California Institute of Technology, MC 127-72, 1200 E. California Blvd, Pasadena, CA, 91125, USA.
Raphael David LevineInstitute of Chemistry, The Hebrew University of Jerusalem, Jerusalem, 91904, Israel.
James R HeathDivision of Chemistry and Chemical Engineering, California Institute of Technology, MC 127-72, 1200 E. California Blvd, Pasadena, CA, 91125, USA.

Funding

QUANTITATIVE IMAGE ANALYSIS SPECIALIZED RESOURCE COREU54CA119347 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI HEATH, JAMES R. · 2005 to 2009
$17.8M
UCLA Institute for Molecular Medicine (IMED) CoreU54CA151819 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI HOOD, LEROY E · 2010 to 2014
$12.1M
Repurposing of cancer therapeutics for treatment of patients with COVID-19 diseaseU54CA199090 · NCI · INSTITUTE FOR SYSTEMS BIOLOGY · PI HEATH, JAMES R., RIBAS, ANTONI · 2015 to 2020
$11.4M
NCI NIH HHS 5U54CA119347NCI NIH HHS U54 CA119347NCI NIH HHS U54 CA151819NCI NIH HHS U54 CA199090
6 · The paper itself

Abstract

A kinetic, single-cell proteomic study of chemically induced carcinogenesis is interpreted by treating the single-cell data as fluctuations of an open system transitioning between different steady states. In analogy to a first-order transition, phase coexistence and the loss of degrees of freedom are observed. The transition is detected well before the appearance of the traditional biomarker of the carcinogenic transformation.

Indexed as

AnimalsCarcinogenesisCarcinogensHumansPhase TransitionProteomicsSingle-Cell AnalysisCarcinogenscarcinogenesismicrofluidicsphase transitionsingle-cell proteomicssteady state

Identifiers

PMID26780498
PMCPMC4886749

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.